Evidence map›Paper›PMID 42793070›Full record

ReviewBiomolecules2026

State-Dependent FGF Signaling in Satellite Cell-Mediated Skeletal Muscle Regeneration and Pathological Remodeling.

Shuying Fu, Yuhuan Meng, Keying Liang, Meiying Feng

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuying FuSchool of Life Sciences, Zhaoqing University, Zhaoqing 526061, China.ORCID 0009-0004-5073-0682
Yuhuan MengGuangzhou KingMed Transformative Medicine Institute & KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 511436, China.ORCID 0000-0001-7464-3103
Keying LiangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0008-9238-4959
Meiying FengSchool of Life Sciences, Zhaoqing University, Zhaoqing 526061, China.

Funding

2025 Project for Delivering Scientific and Technological Achievements to Counties and Towns in Support of the "Hundreds, Thousands and Tens of Thousands Project" 2025B0202010052Guangdong Basic and Applied Basic Research Foundation 2023A1515110973Key Field Special Project of Guangdong Provincial Colleges and Universities 2025ZDZX2077National Natural Science Foundation of China 82302104Zhaoqing Science and Technology Innovation Guided Project 241213014168704
6 · The paper itself

Abstract

Skeletal muscle regeneration depends on coordinated transitions of muscle stem cells (MuSCs), also known as satellite cells, from quiescence through activation and proliferative expansion to differentiation and fusion, while self-renewal replenishes the quiescent MuSC pool within a dynamically remodeled niche. Fibroblast growth factor (FGF) signaling regulates these transitions, but its effects vary as MuSCs and their niche change across regenerative stages. FGF output is shaped by ligand availability and extracellular presentation, fibroblast growth factor receptor (FGFR) isoform expression and coreceptor availability, receptor trafficking, intracellular feedback, and the state of the responding cell. Following acute injury, FGF inputs can support MuSC activation and expansion; signaling is subsequently reconfigured during differentiation, fusion, self-renewal, and return to quiescence. Aging-associated regenerative decline, chronic injury and dystrophic remodeling, denervation, and metabolic dysfunction disrupt this coordination and can uncouple FGF activity from productive repair. Rhabdomyosarcoma provides a distinct malignant context in which the FGF network is rewired to sustain oncogenic myogenic cell states. Here, we integrate molecular, cellular, and niche-level evidence across these settings to explain why FGF signaling produces divergent outcomes and to clarify how cellular context and timing should inform therapeutic modulation.

Indexed as

Fibroblast Growth FactorsMuscle, SkeletalRegenerationSatellite Cells, Skeletal MuscleAnimalsCell DifferentiationHumansReceptors, Fibroblast Growth FactorSignal TransductionFibroblast Growth FactorsReceptors, Fibroblast Growth Factoragingfibroblast growth factormuscle stem cellspathological remodelingregenerative nicherhabdomyosarcomaskeletal muscle regenerationstate-dependent signaling

Identifiers

PMID42793070
PMCPMC13604129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.